CHU de Limoges - Fédération Hépatologie
About CHU de Limoges - Fédération Hépatologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
2
Janssen Research & Development, LLC
2
University Hospital, Limoges
1
Clinical Trials at CHU de Limoges - Fédération Hépatologie
During the past decade, CHU de Limoges - Fédération Hépatologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus
2011-12-01
2015-12-01
Completed
216
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
2017-02-13
2019-06-19
Terminated
808
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
2017-01-30
2019-05-06
Terminated
883
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
2017-10-05
2024-08-16
Active, not recruiting
416
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
2017-11-07
2025-12-22
Active, not recruiting
390
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CHU de Limoges - Fédération Hépatologie
According to Clinical.Site data, the most researched conditions in "CHU de Limoges - Fédération Hépatologie" are
"Nonalcoholic Steatohepatitis" (2 trials), "Amyloidosis" (1 trials), "Hepatitis B" (1 trials), "Renal Failure With Tubular Necrosis" (1 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "CHU de Limoges - Fédération Hépatologie" in a lesser frequency.
Clinical Trials Intervention Types at CHU de Limoges - Fédération Hépatologie
Most popular intervention types in "CHU de Limoges - Fédération Hépatologie" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials), "Bortezomib" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHU de Limoges - Fédération Hépatologie
The vast majority of trials in "CHU de Limoges - Fédération Hépatologie" are
5 trials for "All" genders.
Clinical Trials Status at CHU de Limoges - Fédération Hépatologie
Currently, there are NaN active trials in "CHU de Limoges - Fédération Hépatologie".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in CHU de Limoges - Fédération Hépatologie,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in CHU de Limoges - Fédération Hépatologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".